Medeologix Acquires Mediballoon, MedeonBio and Second Source Medical
November 28, 2022
Medeologix, a Taiwan-based MedTech CDMO, acquired three Silicon Valley contract manufacturers — Mediballoon, MedeonBio and Second Source Medical — to create an integrated end-to-end medical device development and manufacturing group. The combined organization brings together tubing extrusion, balloon forming, catheter processing, assembly, packaging and regulatory support, and links U.S. development centers with Medeologix's mass-production facility in Taiwan to support scale-up and commercialization.
- Buyers
- Medeologix
- Targets
- Mediballoon, MedeonBio, Second Source Medical
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Kimball Electronics Acquires Helvoet Polymer Technologies B.V.
July 3, 2026
Healthcare Services
Kimball Electronics, Inc. has agreed to acquire Helvoet Polymer Technologies B.V., a European-based medical CDMO specializing in microfluidics, diagnostics, and drug delivery. The deal is valued at €90 million (approximately $103 million) and is expected to strengthen Kimball’s global medical CMO platform with added capabilities and manufacturing footprint across Europe, India, and the U.S.
-
Marketlab Acquires Assets of Medi‑Tech International Corporation
September 12, 2023
Medical Devices
Marketlab, a family-owned manufacturer of specialty healthcare products based in Caledonia, Michigan, has acquired the assets of Medi‑Tech International Corporation, a Brooklyn, New York‑based manufacturer of wound care, labor‑and‑delivery, and patient safety products. The acquisition expands Marketlab’s medical‑surgical and laboratory product portfolio and brings additional products, distribution partnerships, and GPO contracts into its offering to better serve IDNs and other healthcare customers.
-
Cordis Acquires MedAlliance
October 17, 2022
Medical Devices
Cordis, the interventional cardiovascular device company, announced the acquisition of Switzerland-based MedAlliance, developer of the SELUTION SLR sirolimus drug‑eluting balloon. The deal includes an initial $35M investment, $200M payable at closing (expected 2023), plus up to $125M in regulatory milestones and up to $775M in commercial milestones through 2029; Cordis will begin co-promotion of SELUTION SLR in markets where it is available.
-
Laborie Medical Technologies Acquires Pelvalon
October 13, 2021
Medical Devices
Laborie Medical Technologies Corp., a specialist medical technology company headquartered in Portsmouth, New Hampshire, has acquired Pelvalon, Inc., a Redwood City, California-based medical device company. Pelvalon’s Eclipse System is an FDA-cleared, non-surgical, patient-controlled device for women with fecal incontinence; the acquisition expands Laborie’s portfolio in pelvic floor and women’s health therapies.
-
Salona Global Medical Device Corp. Acquires Simbex, LLC
September 30, 2021
Medical Devices
Salona Global Medical Device Corporation (SGMD) acquired Simbex, LLC, an IP-driven medical device design and product company that generated approximately US$8.0 million in 2020 revenue. The acquisition is intended to expand SGMD’s recovery-medicine product portfolio, leverage manufacturing capabilities, and increase annualized run-rate revenues to over $24 million.
-
Ergomed plc Acquires MS Clinical Services (MedSource)
December 14, 2020
Healthcare Services
Ergomed plc has acquired MS Clinical Services, LLC (MedSource), a Houston-based full-service CRO specializing in oncology and rare disease, for an initial $16.2 million in cash plus potential shares and contingent consideration. The acquisition expands Ergomed's US footprint (adding ~110 US employees and offices in Houston, Raleigh and Boston), strengthens its specialist clinical research capabilities and is expected to be immediately accretive.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.